Drug intelligence / Profile preview

Collagran Ag

Development stage
Unknown
Lead developer
Angelini
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Collagran Ag is an advanced bioactive wound dressing that combines a bovine-derived collagen matrix with the antimicrobial properties of silver. The collagen component acts as a sacrificial substrate for matrix metalloproteinases (MMPs), which are often elevated in chronic wounds and can impede the healing process by degrading growth factors and the extracellular matrix. By modulating the wound environment and providing a structural scaffold, the collagen promotes fibroblast migration and tissue regeneration. The integrated silver provides broad-spectrum antimicrobial activity by releasing silver ions that disrupt bacterial cell membranes, respiratory chains, and DNA replication, thereby reducing bioburden and preventing infection. It is primarily indicated for the management of chronic and acute wounds, including pressure ulcers, diabetic foot ulcers, venous stasis ulcers, and surgical wounds.

Brand names
Collagran Ag
Other names
Silver Collagen Wound DressingCollagen with Silver
02

Targets

NeuraminidaseMMP12 (Macrophage Metalloelastase)

Beyond the preview

Go deeper on Collagran Ag.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagran Ag.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call